Related Experiment Video
Updated: Aug 9, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Metabolic changes during cell growth inhibition by p27 overexpression
A V Carvalhal1, I Marcelino, M J T Carrondo
1Instituto de Biologia Experimental e Tecnológica/Instituto de Tecnologia Química e Biológica IBET/ITQB, Apartado 12, 2781-901 Oeiras, Portugal.
Abstract:
The overexpression of p27, a cyclin-dependent kinase (CDK) inhibitor, has been shown to effectively inhibit cell growth at the G1-phase of different cell lines, potentiating a valid genetic strategy for cell proliferation control. In order to characterize the energy requirements after p27 overexpression in CHO cells expressing SEAP (secreted form of the human alkaline phosphatase enzyme), key metabolic parameters were evaluated. Cell growth inhibition led to a significant increase in cell size concomitant with a 2-fold increase in cell protein content. The simultaneous increase of the intracellular proteolytic activity with protein content suggests higher protein synthesis. A general 2-fold increase in oxygen, glutamine and glucose consumption rates, coupled with an increase in lactate and ammonia production was observed. p27 overexpression led to a significant increase in the intracellular pool of AMP (8.5-fold), ADP (6-fold) and, more uncommonly, ATP (4.5-fold). Nevertheless, cells were able to maintain the equilibrium among the three adenine nucleotides since both the ATP/ADP ratio and the energy charge values remained similar to those observed with non-growth inhibited cells. This work shows that the observed 4-fold increase in SEAP specific productivity after cell growth inhibition by p27, occurred concomitantly with a higher expenditure of cell energy. This characterization of cell metabolism becomes important in demonstrating the applicability of growth inhibition systems.
Insights
Overexpressing p27, a cell growth inhibitor, increases energy use and protein production in CHO cells. This metabolic shift enhances SEAP productivity, showcasing the utility of growth inhibition systems for bioprocessing.
Area of Science:
- Biotechnology
- Cell Biology
- Metabolic Engineering
Background:
- p27 (cyclin-dependent kinase inhibitor) overexpression effectively halts cell proliferation at G1 phase.
- This strategy offers potential for controlling cell proliferation in various cell lines.
Purpose of the Study:
- To investigate the metabolic demands and energy requirements in CHO cells overexpressing p27.
- To evaluate key metabolic parameters and their impact on SEAP productivity.
Main Methods:
- CHO cells overexpressing p27 and SEAP were analyzed.
- Cellular growth, protein content, proteolytic activity, nutrient consumption (oxygen, glutamine, glucose), waste production (lactate, ammonia), and adenine nucleotide pools (AMP, ADP, ATP) were measured.
Main Results:
- p27 overexpression increased cell size and protein content twofold, indicating enhanced protein synthesis.
- Nutrient consumption and waste production doubled, with significant increases in intracellular AMP, ADP, and ATP pools.
- Despite altered nucleotide pools, cellular energy charge and ATP/ADP ratio remained stable.
- SEAP specific productivity increased fourfold, correlating with increased energy expenditure.
Conclusions:
- p27-induced growth inhibition elevates cellular energy expenditure and protein synthesis in CHO cells.
- This metabolic reprogramming enhances SEAP specific productivity, validating growth inhibition as a valuable bioprocessing tool.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of CDK Activity

